OCREVUS contains the active substance Ocrelizumab. It is used for the treatment of relapsing forms of multiple sclerosis ( a condition in which the immune system attacks the protective covering of the nerves called myelin, causing disrupted communication between the brain and body), to include clinically isolated syndrome, relapsing-remitting disease, active secondary progressive disease and primary progressive multiple sclerosis in adults.

It belongs to the group of medicines called monoclonal antibody targets the CD20 protein on B cells, playing a crucial role in the progression of multiple sclerosis. It offers a targeted approach to managing the disease in patients.

Inform the doctor if you have any active infection, low immune system, hepatitis B, injury, stomach issues, proteinuria, diabetes, hypertension or heart problems, kidney problems and liver problems (such as hepatic injury).

Inform the doctor about all your medical conditions, prescription and non-prescription drugs, vitamin supplements, herbal medications, since OCREVUS can interact with them. OCREVUS can cause an allergic reaction in some patients therefore it is necessary to read the complete composition list and consult the doctor in case of any ingredient that induces allergies.

Consult the doctor if you are planning, on a pregnancy or breastfeeding.

It is advisable to avoid driving and operating heavy machinery during the course of OCREVUS.